{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T08:48:41Z","timestamp":1794646121455,"version":"4.9.1"},"reference-count":151,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2004,11,18]],"date-time":"2004-11-18T00:00:00Z","timestamp":1100736000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2005,2]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>\n                    Despite decades of clinical and laboratory research, relatively little has been accomplished concerning the pathogenesis as well as the identification of risk factors for thrombosis and bleeding in myeloproliferative disorders. In polycythaemia vera, the pro\u2010thrombotic effect of an elevated haematocrit is well established. In contrast, thrombocytosis\n                    <jats:italic>per se<\/jats:italic>\n                    has not been similarly incriminated in essential thrombocythaemia. In both conditions, advanced age and the presence of a prior event identify thrombosis\u2010prone patients. There is increasing evidence to suggest an additional role by leucocytes that might partly explain the antithrombotic effects of myelosuppressive therapy. A substantial minority of affected patients display reduced levels of high molecular weight von Willebrand protein in the plasma during extreme thrombocytosis and it is believed that this might explain the bleeding diathesis of such patients. Recent controlled studies support the therapeutic value of hydroxyurea and aspirin in essential thrombocythaemia and polycythaemia vera, respectively. The current communication will address the incidence, phenotype, pathogenesis, risk factors, prevention, and treatment of both thrombosis and haemorrhage in these disorders.\n                  <\/jats:p>","DOI":"10.1111\/j.1365-2141.2004.05277.x","type":"journal-article","created":{"date-parts":[[2005,1,24]],"date-time":"2005-01-24T08:49:11Z","timestamp":1106556551000},"page":"275-290","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":375,"title":["Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia"],"prefix":"10.1111","volume":"128","author":[{"given":"M. A.","family":"Elliott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Tefferi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,1,24]]},"reference":[{"issue":"5","key":"e_1_2_34_2_1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/039139889301605s40","article-title":"Therapeutic thrombocytapheresis: a review of 132 patients","volume":"16","author":"Adami R.","year":"1993","journal-title":"International Journal of Artificial Organs"},{"key":"e_1_2_34_3_1","first-page":"471a","article-title":"Hemostatic gene polymorphisms and the prevalence of thrombohemorrhagic complications in polycythemia vera and essential thrombocythemia","volume":"98","author":"Afshar\u2010Kharghan V.L.A.","year":"2001","journal-title":"Blood"},{"key":"e_1_2_34_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.10254"},{"key":"e_1_2_34_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00329494"},{"key":"e_1_2_34_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01725198"},{"key":"e_1_2_34_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.324.7329.71"},{"key":"e_1_2_34_8_1","first-page":"143","article-title":"In utero morphological effects of hydroxyurea on the fetal development in Sprague\u2013Dawley rats","volume":"36","author":"Asano Y.","year":"1987","journal-title":"Jikken Dobutsu"},{"key":"e_1_2_34_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1988.tb00835.x"},{"key":"e_1_2_34_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/95.1.82"},{"key":"e_1_2_34_11_1","first-page":"202","article-title":"Indications for cytoreductive therapy in polycythemia vera and essential thrombocythemia","volume":"2003","author":"Barbui T.","year":"2003","journal-title":"Hematology"},{"key":"e_1_2_34_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/0277-5379(83)90091-3"},{"key":"e_1_2_34_13_1","first-page":"215","article-title":"Practice guidelines for the therapy of essential thrombocythemia. A statement from the Italian Society of Experimental Hematology","volume":"89","author":"Barbui T.","year":"2004","journal-title":"Haematologica"},{"key":"e_1_2_34_14_1","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1001\/archderm.1985.01660120042017","article-title":"Treatment of urticaria pigmentosa with corticosteroids","volume":"121","author":"Barton J.","year":"1985","journal-title":"Archives of Dermatology"},{"key":"e_1_2_34_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002770050555"},{"key":"e_1_2_34_16_1","first-page":"455","article-title":"Preliminary report on platelet concentration in capillary tube flows of whole blood","volume":"17","author":"Beck M.R.","year":"1980","journal-title":"Biorheology"},{"key":"e_1_2_34_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19861201)58:11<2440::AID-CNCR2820581115>3.0.CO;2-Y"},{"key":"e_1_2_34_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198102193040801"},{"key":"e_1_2_34_19_1","first-page":"132","article-title":"Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols","volume":"23","author":"Berk P.D.","year":"1986","journal-title":"Seminars in Hematology"},{"key":"e_1_2_34_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401270"},{"key":"e_1_2_34_21_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198801143180215"},{"key":"e_1_2_34_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002779900136"},{"key":"e_1_2_34_23_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-996119"},{"key":"e_1_2_34_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V64.5.981.981"},{"key":"e_1_2_34_25_1","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1182\/blood.V68.6.1213.1213","article-title":"Subunit composition of plasma von Willebrand factor in patients with the myeloproliferative syndrome","volume":"68","author":"Budde U.","year":"1986","journal-title":"Blood"},{"key":"e_1_2_34_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V82.6.1749.1749"},{"key":"e_1_2_34_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1984.tb02912.x"},{"key":"e_1_2_34_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830200408"},{"key":"e_1_2_34_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830280115"},{"key":"e_1_2_34_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01307724"},{"key":"e_1_2_34_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-472X(01)00640-3"},{"key":"e_1_2_34_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19910601)67:11<2926::AID-CNCR2820671136>3.0.CO;2-3"},{"key":"e_1_2_34_33_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1990.8.3.556"},{"key":"e_1_2_34_34_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199504273321704"},{"key":"e_1_2_34_35_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V6.4.372.372"},{"key":"e_1_2_34_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510310307"},{"key":"e_1_2_34_37_1","first-page":"111a","article-title":"V Leiden mutations, prothromin and methylene\u2010tetrahydrofolate reductase are not risk factors for thromboembolic disease in essential thrombocythemia","volume":"94","author":"Dicato M.A.","year":"1999","journal-title":"Blood"},{"key":"e_1_2_34_38_1","first-page":"337","article-title":"Antineoplastic agents and pregnancy","volume":"16","author":"Doll D.C.","year":"1989","journal-title":"Seminars in Oncology"},{"key":"e_1_2_34_39_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-996123"},{"key":"e_1_2_34_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1521-6926(03)00019-7"},{"key":"e_1_2_34_41_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.13.4261"},{"key":"e_1_2_34_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/1096-8652(200010)65:2<136::AID-AJH8>3.0.CO;2-6"},{"key":"e_1_2_34_43_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1613768"},{"key":"e_1_2_34_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19900801)66:3<549::AID-CNCR2820660324>3.0.CO;2-6"},{"key":"e_1_2_34_45_1","doi-asserted-by":"publisher","DOI":"10.1159\/000206299"},{"key":"e_1_2_34_46_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.02188.x"},{"key":"e_1_2_34_47_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.10.4223.bloodjournal87104223"},{"key":"e_1_2_34_48_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-02-0441"},{"key":"e_1_2_34_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(199906)61:2<153::AID-AJH15>3.0.CO;2-Z"},{"key":"e_1_2_34_50_1","first-page":"73","article-title":"Erythromelalgic, thrombotic and haemorrhagic manifestations of thrombocythaemia","volume":"23","author":"Genderen P.J.","year":"1994","journal-title":"Presse Medicale"},{"key":"e_1_2_34_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01698487"},{"key":"e_1_2_34_52_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1653752"},{"key":"e_1_2_34_53_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1650579"},{"key":"e_1_2_34_54_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.d01-1729.x"},{"key":"e_1_2_34_55_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-996113"},{"key":"e_1_2_34_56_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.4823285.x"},{"key":"e_1_2_34_57_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002770050345"},{"key":"e_1_2_34_58_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.d01-2127.x"},{"key":"e_1_2_34_59_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V74.7.2330.2330"},{"key":"e_1_2_34_60_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1999.01340.x"},{"key":"e_1_2_34_61_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-0968.2002.00394.x"},{"key":"e_1_2_34_62_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-1101(2000)15:1\/2<28::AID-JCA4>3.0.CO;2-N"},{"key":"e_1_2_34_63_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-123-9-199511010-00003"},{"key":"e_1_2_34_64_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V93.2.417"},{"key":"e_1_2_34_65_1","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1055\/s-0037-1613087","article-title":"Patients with essential thrombocythaemia have an increased prevalence of antiphospholipid antibodies which may be associated with thrombosis","volume":"87","author":"Harrison C.N.","year":"2002","journal-title":"Thrombosis and Haemostasis"},{"key":"e_1_2_34_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3495(93)81080-4"},{"key":"e_1_2_34_67_1","doi-asserted-by":"publisher","DOI":"10.1007\/s005950050044"},{"key":"e_1_2_34_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2004.03.002"},{"key":"e_1_2_34_69_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002770000244"},{"key":"e_1_2_34_70_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0609.2000.90236.x"},{"key":"e_1_2_34_71_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.02030.x"},{"key":"e_1_2_34_72_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0609.2001.00359.x"},{"key":"e_1_2_34_73_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.10054"},{"key":"e_1_2_34_74_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1987.tb01293.x"},{"key":"e_1_2_34_75_1","first-page":"167","article-title":"Long\u2010term management of polycythemia vera with hydroxyurea: a progress report","volume":"23","author":"Kaplan M.E.","year":"1986","journal-title":"Seminars in Hematology"},{"key":"e_1_2_34_76_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.1.128"},{"key":"e_1_2_34_77_1","first-page":"209","article-title":"Morbidity and mortality of incidental splenectomy","volume":"20","author":"Kassum D.","year":"1977","journal-title":"Canadian Journal of Surgery"},{"key":"e_1_2_34_78_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197809072991002"},{"key":"e_1_2_34_79_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1982.tb01900.x"},{"key":"e_1_2_34_80_1","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.5858\/2002-126-1367-HAT","article-title":"Hyperhomocyst(e)inemia and Thrombophilia","volume":"126","author":"Key N.S.","year":"2002","journal-title":"Archives of Pathology and Laboratory Medicine"},{"key":"e_1_2_34_81_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-996124"},{"key":"e_1_2_34_82_1","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1182\/blood.V80.8.1965.1965","article-title":"Increased thromboxane biosynthesis in patients with polycythemia vera: evidence for aspirin\u2010suppressible platelet activation in vivo. [see comment]","volume":"80","author":"Landolfi R.","year":"1992","journal-title":"Blood"},{"key":"e_1_2_34_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/1040-8428(94)00164-O"},{"key":"e_1_2_34_84_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa035572"},{"key":"e_1_2_34_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-3848(98)00096-6"},{"key":"e_1_2_34_86_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00529.x"},{"key":"e_1_2_34_87_1","doi-asserted-by":"publisher","DOI":"10.1038\/35097008"},{"key":"e_1_2_34_88_1","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1055\/s-0038-1645964","article-title":"Abnormal structure of von Willebrand factor in myeloproliferative syndrome is associated to either thrombotic or bleeding diathesis","volume":"58","author":"Lopez\u2010Fernandez M.F.","year":"1987","journal-title":"Thrombosis and Haemostasis"},{"key":"e_1_2_34_89_1","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800730915"},{"key":"e_1_2_34_90_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1989.tb07755.x"},{"key":"e_1_2_34_91_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200210270-00006"},{"key":"e_1_2_34_92_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra020282"},{"key":"e_1_2_34_93_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-996106"},{"key":"e_1_2_34_94_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-102-4-466"},{"key":"e_1_2_34_95_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.43.6.1107"},{"key":"e_1_2_34_96_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199609074362"},{"key":"e_1_2_34_97_1","doi-asserted-by":"publisher","DOI":"10.1053\/beha.2001.0141"},{"key":"e_1_2_34_98_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1987.00285.x"},{"key":"e_1_2_34_99_1","article-title":"The natural history of PV and ET","author":"Passamonti F.","year":"2004","journal-title":"American Journal of Medicine"},{"key":"e_1_2_34_100_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.0007-1048.2002.03367.x"},{"key":"e_1_2_34_101_1","first-page":"13","article-title":"Polycythemia vera in young patients: a study on the long\u2010term risk of thrombosis, myelofibrosis and leukemia. [comment]","volume":"88","author":"Passamonti F.","year":"2003","journal-title":"Haematologica"},{"key":"e_1_2_34_102_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.119.1_suppl.39S"},{"key":"e_1_2_34_103_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-996120"},{"key":"e_1_2_34_104_1","doi-asserted-by":"publisher","DOI":"10.1053\/sonc.2002.33756"},{"key":"e_1_2_34_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(78)92098-6"},{"key":"e_1_2_34_106_1","first-page":"543","article-title":"Is polycythemia vera a serious disease in young adults","volume":"86","author":"Perea G.","year":"2001","journal-title":"Haematologica"},{"key":"e_1_2_34_107_1","first-page":"51","article-title":"Anagrelide for control of thrombocythemia in polycythemia and other myeloproliferative disorders","volume":"34","author":"Petitt R.M.","year":"1997","journal-title":"Seminars in Hematology"},{"key":"e_1_2_34_108_1","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.5858\/2002-126-1304-CUOFVL","article-title":"Clinical utility of factor V leiden (R506Q) testing for the diagnosis and management of thromboembolic disorders","volume":"126","author":"Press R.D.","year":"2002","journal-title":"Archives of Pathology and Laboratory Medicine"},{"key":"e_1_2_34_109_1","first-page":"213","article-title":"Thrombosis and hemorrhage in thrombocytosis: evaluation of a large cohort of patients (357 cases)","volume":"22","author":"Randi M.L.","year":"1991","journal-title":"Journal of Medicine"},{"key":"e_1_2_34_110_1","doi-asserted-by":"publisher","DOI":"10.1177\/107602969900500210"},{"key":"e_1_2_34_111_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.1331b.x"},{"key":"e_1_2_34_112_1","first-page":"1180","article-title":"Splenectomy after portal thrombosis in patients with polycythemia vera and essential thrombocythemia","volume":"87","author":"Randi M.L.","year":"2002","journal-title":"Haematologica"},{"key":"e_1_2_34_113_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(199711)56:3<168::AID-AJH6>3.0.CO;2-W"},{"key":"e_1_2_34_114_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830310308"},{"key":"e_1_2_34_115_1","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1055\/s-0038-1649916","article-title":"Increased thromboxane biosynthesis in essential thrombocythemia","volume":"74","author":"Rocca B.","year":"1995","journal-title":"Thrombosis Haemostasis"},{"key":"e_1_2_34_116_1","first-page":"171","article-title":"Risk factors for venous thrombosis: prevalence, risk, and interaction","volume":"34","author":"Rosendaal F.R.","year":"1997","journal-title":"Seminars in Hematology"},{"key":"e_1_2_34_117_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19910515)67:10<2658::AID-CNCR2820671042>3.0.CO;2-C"},{"key":"e_1_2_34_118_1","doi-asserted-by":"publisher","DOI":"10.1053\/beha.2001.0133"},{"key":"e_1_2_34_119_1","first-page":"18","article-title":"Is ticlopidine a safe alternative to aspirin for management of myeloproliferative disorders","volume":"78","author":"Ruggeri M.","year":"1993","journal-title":"Haematologica"},{"key":"e_1_2_34_120_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.01021.x"},{"key":"e_1_2_34_121_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.10153"},{"key":"e_1_2_34_122_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1613992"},{"key":"e_1_2_34_123_1","doi-asserted-by":"publisher","DOI":"10.2302\/kjm.37.54"},{"key":"e_1_2_34_124_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198202183060701"},{"key":"e_1_2_34_125_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V64.1.1.1"},{"key":"e_1_2_34_126_1","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1182\/blood.V100.5.1596.h81702001596_1596_1601","article-title":"Predictive values of X\u2010chromosome inactivation patterns and clinicohematologic parameters for vascular complications in female patients with essential thrombocythemia","volume":"100","author":"Shih L.Y.","year":"2002","journal-title":"Blood"},{"key":"e_1_2_34_127_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.3503164.x"},{"key":"e_1_2_34_128_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.13.1645"},{"key":"e_1_2_34_129_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.2.616"},{"key":"e_1_2_34_130_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.4.863"},{"key":"e_1_2_34_131_1","first-page":"172","article-title":"Adverse effects of antiaggregating platelet therapy in the treatment of polycythemia vera","volume":"23","author":"Tartaglia A.P.","year":"1986","journal-title":"Seminars in Hematology"},{"key":"e_1_2_34_132_1","doi-asserted-by":"publisher","DOI":"10.4065\/78.2.174"},{"key":"e_1_2_34_133_1","doi-asserted-by":"publisher","DOI":"10.1054\/blre.2001.0158"},{"key":"e_1_2_34_134_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-996112"},{"key":"e_1_2_34_135_1","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1182\/blood.V95.7.2226","article-title":"Splenectomy in myelofibrosis with myeloid metaplasia: a single\u2010 institution experience with 223 patients","volume":"95","author":"Tefferi A.","year":"2000","journal-title":"Blood"},{"key":"e_1_2_34_136_1","doi-asserted-by":"publisher","DOI":"10.4065\/76.1.22"},{"key":"e_1_2_34_137_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.10.4235.bloodjournal87104235"},{"key":"e_1_2_34_138_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1983.tb35199.x"},{"key":"e_1_2_34_139_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830330205"},{"key":"e_1_2_34_140_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-103-3-329"},{"key":"e_1_2_34_141_1","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.5858\/2002-126-1281-LEOHWV","article-title":"Laboratory evaluation of hypercoagulability with venous or arterial thrombosis","volume":"126","author":"Van Cott E.M.","year":"2002","journal-title":"Archives of Pathology and Laboratory Medicine"},{"key":"e_1_2_34_142_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.283.6293.689"},{"key":"e_1_2_34_143_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.20.2518"},{"key":"e_1_2_34_144_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1993.tb08272.x"},{"key":"e_1_2_34_145_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.6.1232"},{"key":"e_1_2_34_146_1","first-page":"251","article-title":"Bleeding and thrombosis in chronic myeloproliferative disorders: relation of platelet disorders to clinical aspects of the disease","volume":"19","author":"Wehmeier A.","year":"1989","journal-title":"Haemostasis"},{"key":"e_1_2_34_147_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1990.tb00456.x"},{"key":"e_1_2_34_148_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01707281"},{"key":"e_1_2_34_149_1","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(91)90103-4"},{"key":"e_1_2_34_150_1","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1182\/blood.V54.6.1296.1296","article-title":"Heterogeneity in storage pool deficiency: studies on granule\u2010bound substances in 18 patients including variants deficient in alpha\u2010granules, platelet factor 4, beta\u2010thromboglobulin, and platelet\u2010derived growth factor","volume":"54","author":"Weiss H.J.","year":"1979","journal-title":"Blood"},{"key":"e_1_2_34_151_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0268-960X(98)90026-1"},{"key":"e_1_2_34_152_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-88-1-7"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2004.05277.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2004.05277.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T03:19:35Z","timestamp":1697426375000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2004.05277.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1,24]]},"references-count":151,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["10.1111\/j.1365-2141.2004.05277.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2004.05277.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1,24]]},"assertion":[{"value":"2005-01-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}